The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies

Autor: Potter, R., Tanderup, K., Kirisits, C., Leeuw, A. de, Kirchheiner, K., Nout, R., Tan, L.T., Haie-Meder, C., Mahantshetty, U., Segedin, B., Hoskin, P., Bruheim, K., Rai, B., Huang, F., Limbergen, E. van, Schmid, M., Nesvacil, N., Sturdza, A., Fokdal, L., Jensen, N.B.K., Georg, D., Assenholt, M., Seppenwoolde, Y., Nomden, C., Fortin, I., Chopra, S., Heide, U. van der, Rumpold, T., Lindegaard, J.C., Jurgenliemk-Schulz, I., Dumas, I., Chargari, C., Swamidas, J., Shrivastava, S.K., Lowe, G., Hudej, R., Hellebust, T.P., Menon, G., Oinam, A.S., Cooper, R., Bownes, P., Banasik, E.V., Sundset, M., Pieters, B., Lutgens, L.C.H.W., Villafranca, E., Hadjiev, J., Bachand, F., Erickson, B., Jacobson, G., Anttila, M., EMBRACE Collaborative Grp

Publikováno v: EMBRACE Collaborative Group 2018, ' The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies ', Clinical and Translational Radiation Oncology, vol. 9, pp. 48-60 . https://doi.org/10.1016/j.ctro.2018.01.001
Clinical and Translational Radiation Oncology, Vol 9, Iss C, Pp 48-60 (2018)
EMBRACE Collaborative Group 2018, ' The EMBRACE II study : The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies ', Clinical and translational radiation oncology, vol. 9, pp. 48-60 . https://doi.org/10.1016/j.ctro.2018.01.001
Clinical and Translational Radiation Oncology

Graphical abstract
Highlights • Image guided adaptive brachytherapy (IGABT) is changing clinical practice. • The EMBRACE studies benchmark IGABT in cervix cancer. • A multi-parametric dose prescription protocol is being validated in EMBRAC

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e579cd8e34c0991ab2e1393794dc36d0
https://doi.org/10.1016/j.ctro.2018.01.001

P4-09-07: Breast Cancer Outcome by Combined Immunohistochemical ER/PR/HER2 Receptor Phenotype

Autor: Robert Paridaens, Ignace Vergote, Olivier Brouckaert, Annouschka Laenen, Patrick Berteloot, A Smeets, Patrick Neven, A Reynders, H. Wildiers, Limbergen E Van, P. Moerman, Caroline Weltens, Karin Leunen, Frédéric Amant, M-R Christiaens, Joke Vanderhaegen

Publikováno v: Cancer Research. 71:P4-09

Introduction: We previously reported that molecular prognostic subgroup classification of operable breast cancers resembles the classification based on combined immunohistochemical expression of ER, PR and HER-2 receptors. This update represents a la

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::211113f14f837dbd973e78b387db999b
https://doi.org/10.1158/0008-5472.sabcs11-p4-09-07

Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

Autor: Mavaddat, N., Pharoah, P.D.P., Michailidou, K., Tyrer, J., Brook, M.N., Bolla, M.K., Wang, Q., Dennis, J., Dunning, A.M., Shah, M., Luben, R., Brown, J., Bojesen, S.E., Nordestgaard, B.G., Nielsen, S.F., Flyger, H., Czene, K., Darabi, H., Eriksson, M., Peto, J., dos-Santos-Silva, I., Dudbridge, F., Johnson, N., Schmidt, M.K., Broeks, A., Verhoef, S., Rutgers, E.J., Swerdlow, A., Ashworth, A., Orr, N., Schoemaker, M.J., Figueroa, J., Chanock, S.J., Brinton, L., Lissowska, J., Couch, F.J., Olson, J.E., Vachon, C., Pankratz, V.S., Lambrechts, D., Wildiers, H., Ongeval, C. van, Limbergen, E. van, Kristensen, V., Alnaes, G.G., Nord, S., Borresen-Dale, A.L., Nevanlinna, H., Muranen, T.A., Aittomaki, K., Blomqvist, C., Chang-Claude, J., Rudolph, A., Seibold, P., Flesch-Janys, D., Fasching, P.A., Haeberle, L., Ekici, A.B., Beckmann, M.W., Burwinkel, B., Marme, F., Schneeweiss, A., Sohn, C., Trentham-Dietz, A., Newcomb, P., Titus, L., Egan, K.M., Hunter, D.J., Lindstrom, S., Tamimi, R.M., Kraft, P., Rahman, N., Turnbull, C., Renwick, A., Seal, S., Li, J.M., Liu, J.J., Humphreys, K., Benitez, J., Zamora, M.P., Perez, J.I.A., Menendez, P., Jakubowska, A., Lubinski, J., Jaworska-Bieniek, K., Durda, K., Bogdanova, N.V., Antonenkova, N.N., Dork, T., Anton-Culver, H., Neuhausen, S.L., Ziogas, A., Bernstein, L., Devilee, P., Tollenaar, R.A.E.M., Seynaeve, C., Asperen, C.J. van, Cox, A., Cross, S.S., Reed, M.W.R., Khusnutdinova, E., Bermisheva, M., Prokofyeva, D., Takhirova, Z., Meindl, A., Schmutzler, R.K., Sutter, C., Yang, R.X., Schurmann, P., Bremer, M., Christiansen, H., Park-Simon, T.W., Hillemanns, P., Guenel, P., Truong, T., Menegaux, F., Sanchez, M., Radice, P., Peterlongo, P., Manoukian, S., Pensotti, V., Hopper, J.L., Tsimiklis, H., Apicella, C., Southey, M.C., Brauch, H., Bruning, T., Ko, Y.D., Sigurdson, A.J., Doody, M.M., Hamann, U., Torres, D., Ulmer, H.U., Forsti, A., Sawyer, E.J., Tomlinson, I., Kerin, M.J., Miller, N., Andrulis, I.L., Knight, J.A., Glendon, G., Mulligan, A.M., Chenevix-Trench, G., Balleine, R., Giles, G.G., Milne, R.L., McLean, C., Lindblom, A., Margolin, S., Haiman, C.A., Henderson, B.E., Schumacher, F., Marchand, L. le, Eilber, U., Wang-Gohrke, S., Hooning, M.J., Hollestelle, A., Ouweland, A.M.W. van den, Koppert, L.B., Carpenter, J., Clarke, C., Scott, R., Mannermaa, A., Kataja, V., Kosma, V.M., Hartikainen, J.M., Brenner, H., Arndt, V., Stegmaier, C., Dieffenbach, A.K., Winqvist, R., Pylkas, K., Jukkola-Vuorinen, A., Grip, M., Offit, K., Vijai, J., Robson, M., Rau-Murthy, R., Dwek, M., Swann, R., Perkins, K.A., Goldberg, M.S., Labreche, F., Dumont, M., Eccles, D.M., Tapper, W.J., Rafiq, S., John, E.M., Whittemore, A.S., Slager, S., Yannoukakos, D., Toland, A.E., Yao, S., Zheng, W., Halverson, S.L., Gonzalez-Neira, A., Pita, G., Alonso, M.R., Alvarez, N., Herrero, D., Tessier, D.C., Vincent, D., Bacot, F., Luccarini, C., Baynes, C., Ahmed, S., Maranian, M., Healey, C.S., Simard, J., Hall, P., Easton, D.F., Garcia-Closas, M.

Publikováno v: JNCI: Journal of the National Cancer Institute, 107(5)
Journal of the National Cancer Institute; 107(5), pp 036-036 (2015)
Journal of the National Cancer Institute, 107(5). Oxford University Press
JNCI Journal of the National Cancer Institute

Background: Data for multiple common susceptibility alleles for breast cancer may be combined to identify women at different levels of breast cancer risk. Such stratification could guide preventive and screening strategies. However, empirical evidenc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::dfc309152b8507740b68aea1ad926efb
http://hdl.handle.net/1887/105703

The locoregional treatment of clinical stage 1 and 2 carcinomas of the breast. (Dutch)

Autor: Limbergen E. Van

Publikováno v: Plastic and Reconstructive Surgery. 87:392

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::500a9eb7307c0982d524be59347dd98d
https://doi.org/10.1097/00006534-199102000-00061

Quality control in interstitial brachytherapy of the breast using pulsed dose rate: treatment planning and dose delivery with an Ir-192 afterloading system

Autor: Mangold, C. A., Rijnders, A., Georg, D., Limbergen, E. Van, Potter, R., Huyskens, D.

Publikováno v: Radiotherapy and Oncology; 2001, Vol. 58 Issue: 1 p43-51, 9p